Literature DB >> 23084763

Immune responses to Clostridium difficile infection.

Rajat Madan1, William A Petri.   

Abstract

Clostridium difficile is the causal agent of antibiotic-associated diarrhea and is a leading cause of hospital-acquired infections in the US. C. difficile has been known to cause severe diarrhea and colitis for more than 30 years, but the emergence of a newer, hypervirulent strain of C. difficile (BI/NAP1) has further compounded the problem, and recently both the number of cases and mortality associated with C. difficile-associated diarrhea have been increasing. One of the major drivers of disease pathogenesis is believed to be an excessive host inflammatory response. A better understanding of the host inflammation and immune mechanisms that modulate the course of disease and control host susceptibility to C. difficile could lead to novel (host-targeted) strategies for combating the challenges posed by this deadly infection. This review summarizes our current knowledge of the host inflammatory response during C. difficile infection.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23084763      PMCID: PMC3500589          DOI: 10.1016/j.molmed.2012.09.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  91 in total

1.  Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate.

Authors:  D M Lyerly; E F Bostwick; S B Binion; T D Wilkins
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Comparative sequence analysis of the Clostridium difficile toxins A and B.

Authors:  C von Eichel-Streiber; R Laufenberg-Feldmann; S Sartingen; J Schulze; M Sauerborn
Journal:  Mol Gen Genet       Date:  1992-05

3.  Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak.

Authors:  A Thibault; M A Miller; C Gaese
Journal:  Infect Control Hosp Epidemiol       Date:  1991-06       Impact factor: 3.254

4.  Early functional effects of Clostridium difficile toxin A on human colonocytes.

Authors:  J E Branka; G Vallette; A Jarry; C Bou-Hanna; P Lemarre; P N Van; C L Laboisse
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

5.  Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients.

Authors:  L V McFarland; C M Surawicz; W E Stamm
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

6.  Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment.

Authors:  Y R Mahida; S Makh; S Hyde; T Gray; S P Borriello
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

7.  Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine.

Authors:  I Kurose; C Pothoulakis; J T LaMont; D C Anderson; J C Paulson; M Miyasaka; R Wolf; D N Granger
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Heterogeneity of Clostridium difficile isolates from infants.

Authors:  A Collignon; L Ticchi; C Depitre; J Gaudelus; M Delmée; G Corthier
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

9.  Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum.

Authors:  I Castagliuolo; J T LaMont; R Letourneau; C Kelly; J C O'Keane; A Jaffer; T C Theoharides; C Pothoulakis
Journal:  Gastroenterology       Date:  1994-09       Impact factor: 22.682

10.  Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit.

Authors:  C P Kelly; S Becker; J K Linevsky; M A Joshi; J C O'Keane; B F Dickey; J T LaMont; C Pothoulakis
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more
  35 in total

1.  Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.

Authors:  Marco Falcone; Alessandro Russo; Federica Iraci; Paolo Carfagna; Paola Goldoni; Vincenzo Vullo; Mario Venditti
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

Review 2.  Role of obesity and adipose tissue-derived cytokine leptin during Clostridium difficile infection.

Authors:  Rajat Madan; William A Petri
Journal:  Anaerobe       Date:  2015-01-29       Impact factor: 3.331

3.  Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections.

Authors:  Rana E El Feghaly; Jennifer L Stauber; Phillip I Tarr; David B Haslam
Journal:  J Pediatr       Date:  2013-09-04       Impact factor: 4.406

4.  Clostridium difficile-induced colitis in mice is independent of leukotrienes.

Authors:  Bruno C Trindade; Casey M Theriot; Jhansi L Leslie; Paul E Carlson; Ingrid L Bergin; Marc Peters-Golden; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2014-09-16       Impact factor: 3.331

Review 5.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 6.  Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.

Authors:  Milena M Awad; Priscilla A Johanesen; Glen P Carter; Edward Rose; Dena Lyras
Journal:  Gut Microbes       Date:  2014

Review 7.  Clostridium difficile colitis: pathogenesis and host defence.

Authors:  Michael C Abt; Peter T McKenney; Eric G Pamer
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

8.  Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab.

Authors:  Zhiyong Yang; Jeremy Ramsey; Therwa Hamza; Yongrong Zhang; Shan Li; Harris G Yfantis; Dong Lee; Lorraine D Hernandez; Wolfgang Seghezzi; Jamie M Furneisen; Nicole M Davis; Alex G Therien; Hanping Feng
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

Review 9.  Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.

Authors:  Jessica S H Martin; Tanya M Monaghan; Mark H Wilcox
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-03-09       Impact factor: 46.802

Review 10.  Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.

Authors:  Caná L Ross; Jennifer K Spinler; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-12       Impact factor: 3.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.